Search results for: 'cases deviat learning'
- Did you mean
- cases device learning
- cases devic learning
- Related search terms
- Learning and development sklls market
- Learning Expert-Level Racing Strategies Via Scheduled Cost Functions in Model Predictive Control
- Learning+Trends
- learning and development sales market
- learning ad development sales market
-
09 Sep 2025  |  Global  |  Technology Research
Mixed Reality in Healthcare, Global, 2025–2029
Mixed Reality in Healthcare Is Driving Transformational Growth Through Medical Education, Emerging Growth Opportunities, Global Ecosystems, and Advanced Technology Analysis
Mixed reality (MR) merges real and virtual elements to create interactive environments. Workforce shortages, rising training needs, patient engagement gaps, and the shift toward decentralized care are driving demand for immersive technologies in healthcare. By blending virtual and augmented reality, MR enables learners to practice complex clinical ...
$4,950.00 -
22 Oct 2025  |  Global  |  Technology Research
Beyond CRISPR: Recent Technology Advances in Rewriting DNA
Emerging Tools Reshaping the Future of Gene Editing
This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide...
$4,950.00 -
12 May 2025  |  Global  |  Market Research
Clinical Decision Support System Market, Global, 2024–2030
AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes
The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support sy...
$4,950.00
Special Price $4,455.00 save 10 %
-
17 Jan 2025  |  Global  |  Technology Research
Emerging Technology Innovations in Immune-oncology, Precision Medicine and Cell Engineering
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neurop...
$950.00
Special Price $807.50 save 15 %
-
04 Nov 2025  |  North America  |  Frost Radar
Frost Radar™: Revenue Cycle Management Operations in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The revenue cycle management (RCM) operations space is at a structural inflection, and the convergence of technology, regulations, and dynamic buyer expectations is compelling RCM vendors to act and upgrade their value propositions and strategies to remain competitive. Providers have been under significant financial stress in the past few years. Ho...
$4,950.00 -
25 Jul 2025  |  Global  |  Technology Research
Recent Technological Advances across AI-Enabled Drug Discovery, Neurodegenerative Disease Management, and Treatment of Metabolic Diseases
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...
$950.00
Special Price $855.00 save 10 %
-
17 Sep 2025  |  Global  |  Market Research
Innovations in Global Multiomics Technologies for Cancer
Global Trends, Technological Breakthroughs, and Collaborative Pathways Transforming Cancer Care
This study examines how global multiomics technologies are changing the way that cancer is treated, with a focus on new developments, strategic needs, and future directions. By facilitating thorough tumor characterization, early detection, patient stratification, and real-time monitoring, multiomics—an integrated analysis of genomics, transcriptomi...
$4,950.00 -
23 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Documentation Integrity in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...
$4,950.00
Special Price $4,455.00 save 10 %
-
12 Feb 2025  |  Global  |  Customer Research
Global Healthcare Cloud User Survey, Q3 2024
Artificial Intelligence Growth and the Shift to Cloud-native Applications and Edge Computing Drive the Digital Transformation
The story for 2024 is artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI, particularly generative AI (GenAI), to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption among customers by developing foundational models and user-friend...
$4,950.00
Special Price $4,455.00 save 10 %
-
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00